Description
A structural analog of glucagon receptor antagonist I; inhibits glucagon binding GCGR by only 20% in CHO cells expressing human GCGR at 50 µM; has no effect on glucagon-induced glycogenolysis in primary human hepatocytes at 10 or 30 µM
Formal name: 4-bromo-N-[3-cyano-6-(1,1-dimethylpropyl)-4,5,6,7-tetrahydrobenzo[b]thien-2-yl]-benzamide
Synonyms: GCGR Inactive Control
Molecular weight: 431.4
CAS: 362482-00-6
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Endocrinology & Metabolism|Carbohydrate Metabolism||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes